Latent profile analysis of data from the brief inventory of neurocognitive impairment (BINI) to develop neuro-cognitive profiles among opioid-dependent patients in drug treatment

References

• Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367–87. doi:10.1016/S0140-6736(10)60829-X.
   PubMed Web of Science ®Google Scholar
• Kamarulzaman A, Altice FL. Challenges in managing HIV in people who use drugs. Curr Opin Infect Dis. 2015;28(1):10–6. doi:10.1097/QCO.0000000000000125.
   PubMed Web of Science ®Google Scholar
• Rapeli P, Kivisaari R, Autti T, Kähkönen S, Puuskari V, Jokela O, Kalska H. Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry. 2006;6(1):9. doi:10.1186/1471-244X-6-9.
   PubMed Web of Science ®Google Scholar
• Verdejo-García A, López-Torrecillas F, Giménez C, Pérez-García M. Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse. Neuropsychol Rev. 2004;14(1):1–41. doi:10.1023/B:NERV.0000026647.71528.83.
   PubMed Web of Science ®Google Scholar
• Schiltenwolf M, Akbar M, Hug A, Pfüller U, Gantz S, Neubauer E, Flor H, Wang H. Evidence of specific cognitive deficits in patients with chronic low back pain under long-term substitution treatment of opioids. Pain Physician. 2014;17(1):9–20.
   PubMed Web of Science ®Google Scholar
• Anand P, Springer SA, Copenhaver MM, Altice FL. Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav. 2010;14(6):1213–26. doi:10.1007/s10461-010-9684-1.
   PubMed Web of Science ®Google Scholar
• Baldacchino A, Balfour DJK, Passetti F, Humphris G, Matthews K. Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis. Neurosci Biobehav Rev. 10//2012;36(9):2056–68. doi:10.1016/j.neubiorev.2012.06.006.
   PubMed Web of Science ®Google Scholar
• Blume AW, Davis JM, Schmaling KB. Neurocognitive dysfunction in dually-diagnosed patients: a potential roadblock to motivating behavior change. J Psychoactive Drugs. 1999;31(2):111–5. doi:10.1080/02791072.1999.10471732.
   PubMed Web of Science ®Google Scholar
• Morgenstern J, Bates ME. Effects of executive function impairment on change processes and substance use outcomes in 12-step treatment. J Stud Alcohol. 1999;60(6):846–55. doi:10.15288/jsa.1999.60.846.
   PubMed Web of Science ®Google Scholar
• Bates ME, Pawlak AP, Tonigan JS, Buckman JF. Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change. Psychol Addict Behav. 2006;20(3):241–53. doi:10.1037/0893-164X.20.3.241.
   PubMed Web of Science ®Google Scholar
• Nakagami E, Hoe M, Brekke JS. The prospective relationships among intrinsic motivation, neurocognition, and psychosocial functioning in schizophrenia. Schizophr Bull. 2010;36(5):935–48. doi:10.1093/schbul/sbq043.
   PubMed Web of Science ®Google Scholar
• Huedo-Medina TB, Shrestha R, Copenhaver M. Modeling a theory-based approach to examine the influence of neurocognitive impairment on HIV risk reduction behaviors among drug users in treatment. AIDS Behav. 2016;20(8):1646–57. doi:10.1007/s10461-016-1394-x.
   PubMed Web of Science ®Google Scholar
• Ezeabogu I, Copenhaver MM, Potrepka J. The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS. AIDS Care. 2012;24(3):386–93. doi:10.1080/09540121.2011.608794.
   PubMed Web of Science ®Google Scholar
• Hagen E, Sømhovd M, Hesse M, Arnevik EA, Erga AH. Measuring cognitive impairment in young adults with polysubstance use disorder with MoCA or BRIEF-a - the significance of psychiatric symptoms. J Subst Abuse Treat. 2019;97:21–7. doi:10.1016/j.jsat.2018.11.010.
   PubMed Web of Science ®Google Scholar
• Ridley N, Batchelor J, Draper B, Demirkol A, Lintzeris N, Withall A. Cognitive screening in substance users: diagnostic accuracies of the mini-mental state examination, Addenbrooke’s cognitive examination-revised, and montreal cognitive assessment. J Clin Exp Neuropsychol. 2018;40(2):107–22. doi:10.1080/13803395.2017.1316970.
   PubMed Web of Science ®Google Scholar
• Copenhaver M, Shrestha R, Wickersham JA, Weikum D, Altice FL. An exploratory factor analysis of a brief self-report scale to detect neurocognitive impairment among participants enrolled in methadone maintenance therapy. J Subst Abuse Treat. 2016;63:61–5. doi:10.1016/j.jsat.2016.01.002.
   PubMed Web of Science ®Google Scholar
• Copenhaver MM, Sanborn V, Shrestha R, Mistler C, Gunstad J. Association between the brief inventory of neurocognitive impairment (BINI) and objective cognitive testing among persons with opioid use disorders in drug treatment. J Addict Dis. 2021;39(2):166–74. doi:10.1080/10550887.2020.1831129.
   PubMed Web of Science ®Google Scholar
• Olaithe M, Pushpanathan M, Hillman D, Eastwood PR, Hunter M, Skinner T, James A, Wesnes KA, Bucks RS. Cognitive profiles in obstructive sleep apnea: a cluster analysis in sleep clinic and community samples. J Clin Sleep Med. 2020;16(9):1493–505. doi:10.5664/jcsm.8564.
   PubMed Web of Science ®Google Scholar
• Lima F, Rabelo-da-Ponte FD, Bücker J, Czepielewski L, Hasse-Sousa M, Telesca R, Solé B, Reinares M, Vieta E, Rosa AR, et al. Identifying cognitive subgroups in bipolar disorder: a cluster analysis. J Affect Disord. 2019;246:252–61. doi:10.1016/j.jad.2018.12.044.
   PubMed Web of Science ®Google Scholar
• Souza CP, Oliveira GN, Foss MP, Tumas V. Cluster analysis of cognitive performance in a sample of patients with Parkinson’s disease. Dement Neuropsychol. 2016;10(4):315–9. doi:10.1590/s1980-5764-2016dn1004010.
   PubMedGoogle Scholar
• Schmid F, Benzerouk F, Barrière S, Henry A, Limosin F, Kaladjian A, Gierski F. Heterogeneity of executive function abilities in recently detoxified patients with alcohol use disorder: evidence from a cluster analysis. Alcohol Clin Exp Res. 2021;45(1):163–73. doi:10.1111/acer.14517.
   PubMed Web of Science ®Google Scholar
• Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401. doi:10.1177/014662167700100306.
   Web of Science ®Google Scholar
• Heaton RK, Franklin DR, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, et al. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. Feb. 2015;60(3):473–80. 1 doi:10.1093/cid/ciu862.
   PubMed Web of Science ®Google Scholar
• Muthén LK, Muthén BO. Mplus user’s guide. 8th ed. Los Angeles, CA: Muthén & Muthén; 1998. p. 2017.
   Google Scholar
• IBM SPSS Statistics for Windows. Version 25. IBM Corp.; 2017.
   Google Scholar
• Yim O, Ramdeen KT. Hierarchical cluster analysis: comparison of three linkage measures and application to psychological data. Quant Methods Psychol . 2015;11(1):8–21. doi:10.20982/tqmp.11.1.p008.
   Web of Science ®Google Scholar
• Masyn KE. Latent class analysis and finite mixture modeling. In: The Oxford handbook of quantitative methods: statistical analysis. Vol 2. Oxford University Press; 2013. p. 551–611. Oxford, UK: Oxford library of psychology.
   Google Scholar
• Savalei V, Rosseel Y. Computational options for standard errors and test statistics with incomplete normal and nonnormal data in SEM. Struct Equation Model: Multidiscipl J. 2022;29(2):163–81. doi:10.1080/10705511.2021.1877548.
   Web of Science ®Google Scholar
• Hawkins MAW, Schaefer JT, Gunstad J, Dolansky MA, Redle JD, Josephson R, Moore SM, Hughes JW. What is your patient’s cognitive profile? Three distinct subgroups of cognitive function in persons with heart failure. Appl Nurs Res. 2015;28(2):186–91. doi:10.1016/j.apnr.2014.10.005.
   PubMed Web of Science ®Google Scholar
• Nylund KL, Asparouhov T, Muthén BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct Equation Model: Multidiscipl J. 2007;14(4):535–69. doi:10.1080/10705510701575396.
   Web of Science ®Google Scholar
• Burmester B, Leathem J, Merrick P. Subjective cognitive complaints and objective cognitive function in aging: a systematic review and meta-analysis of recent cross-sectional findings. Neuropsychol Rev. 2016;26(4):376–93. doi:10.1007/s11065-016-9332-2.
   PubMed Web of Science ®Google Scholar
• Darke S, McDonald S, Kaye S, Torok M. Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users. Drug Alcohol Depend. 2012;126(3):309–15. doi:10.1016/j.drugalcdep.2012.05.032.
   PubMed Web of Science ®Google Scholar
• Strand MC, Vindenes V, Gjerde H, Morland JG, Ramaekers JG. A clinical trial on the acute effects of methadone and buprenorphine on actual driving and cognitive function of healthy volunteers. Br J Clin Pharmacol. 2019;85(2):442–53. doi:10.1111/bcp.13818.
   PubMed Web of Science ®Google Scholar
• Yeoh SW, Holmes ACN, Saling MM, Everall IP, Nicoll AJ. Depression, fatigue and neurocognitive deficits in chronic hepatitis C. Hepatol Int. 2018;12(4):294–304. doi:10.1007/s12072-018-9879-5.
   PubMed Web of Science ®Google Scholar
• Thein HH, Maruff P, Krahn M, Kaldor JM, Koorey DJ, Brew BJ, Dore GJ. Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment. HIV Med. 2007;8(3):192–202. doi:10.1111/j.1468-1293.2007.00452.x.
   PubMed Web of Science ®Google Scholar
• Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among methadone maintenance patients. Addiction. 2000;95(5):687–95. doi:10.1046/j.1360-0443.2000.9556874.x.
   PubMed Web of Science ®Google Scholar
• Dassanayake TL, Michie PT, Jones A, Carter G, Mallard T, Whyte I. Cognitive impairment in patients clinically recovered from central nervous system depressant drug overdose. J Clin Psychopharmacol. 2012;32(4):503–10. doi:10.1097/JCP.0b013e31825d6ddb.
   PubMed Web of Science ®Google Scholar
• Ghosh A, Basu D, Mattoo SK, Kumar Rana D, Roub F. Does cannabis dependence add on to the neurocognitive impairment among patients with opioid dependence? A cross-sectional comparative study. Am J Addict. 2020;29(2):120–8. doi:10.1111/ajad.12986.
   PubMed Web of Science ®Google Scholar
• Mintzer MZ, Copersino ML, Stitzer ML. Opioid abuse and cognitive performance. Drug Alcohol Depend. 2005;78(2):225–30. doi:10.1016/j.drugalcdep.2004.10.008.
   PubMed Web of Science ®Google Scholar
• Paul R. Neurocognitive phenotyping of HIV in the era of antiretroviral therapy. Curr HIV/AIDS Rep. 2019;16(3):230–5. doi:10.1007/s11904-019-00426-9.
   PubMed Web of Science ®Google Scholar
• Cedres N, Machado A, Molina Y, Diaz-Galvan P, Hernández-Cabrera JA, Barroso J, Westman E, Ferreira D. Subjective cognitive decline below and above the age of 60: a multivariate study on neuroimaging, cognitive, clinical, and demographic measures. J Alzheimer’s Dis . 2019;68(1):295–309. doi:10.3233/JAD-180720.
   PubMed Web of Science ®Google Scholar
• Lista S, Molinuevo JL, Cavedo E, Rami L, Amouyel P, Teipel SJ, Garaci F, Toschi N, Habert M-O, Blennow K, et al. Evolving evidence for the value of neuroimaging methods and biological markers in subjects categorized with subjective cognitive decline. J Alzheimers Dis. 2015;48(Suppl 1):S171–S91. doi:10.3233/jad-150202.
   PubMedGoogle Scholar
• Bach P, Frischknecht U, Reinhard I, Bekier N, Demirakca T, Ende G, Vollstädt-Klein S, Kiefer F, Hermann D. Impaired working memory performance in opioid-dependent patients is related to reduced insula gray matter volume: a voxel-based morphometric study. Eur Arch Psychiatry Clin Neurosci. 2021;271(5):813–22. doi:10.1007/s00406-019-01052-7.
   PubMed Web of Science ®Google Scholar